Exponent EXPO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 19.4%-1.2pp | 20.6%-0.1pp | 20.6%+0.2pp | 20.5%-3.4pp | 23.8%+2.4pp | |
| Net margin | 18.1%-0.1pp | 18.2%-0.1pp | 18.3%0.0pp | 18.3%-0.5pp | 18.9%-0.6pp | |
| Returns | ||||||
| Return on equity | 27.9%+1.8pp | 26.1%+0.3pp | 25.8%+0.7pp | 25.1%-0.8pp | 25.9%-2.2pp | |
| Return on invested capital | 29%-5.8pp | 34.8%+3.7pp | 31.1%+0.4pp | 30.7%-7.4pp | 38.2%-2.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×+0.1× | 0.7×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.4×0.0× | 2.4×-0.3× | 2.7×-0.5× | 3.2×-0.2× | 3.3×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | -0.3×+0.8× | -1.1×-0.1× | -1×+0.2× | -1.2×-0.1× | -1.2×+0.2× | |
| Per Share | ||||||
| Book value per share | $6.75-11.4% | $7.62-3.2% | $7.87-5.2% | $8.31-2.8% | $8.55+4.7% | |
| Valuation | ||||||
| Market capitalization | $3.25B-9.3% | $3.59B+0.3% | $3.58B+2.2% | $3.5B-12.7% | $4.01B-13.8% | |
| Price / earnings | 29.9×-4.0× | 33.8×-0.3× | 34.1×+0.1× | 34×-4.0× | 38×-4.7× | |
| Price / sales | 5.4×-0.8× | 6.2×-0.1× | 6.3×0.0× | 6.2×-0.9× | 7.2×-1.2× | |
| Price / book | 9.6×+0.4× | 9.2×+0.3× | 8.9×+0.7× | 8.2×-0.9× | 9.1×-2.0× | |
| EV / EBITDA | 25.3×-1.2× | 26.5×-0.4× | 27×+0.1× | 26.9×0.0× | 26.9×-7.8× | |
| Dividend yield | 1.9%+0.2pp | 1.7%0.0pp | 1.7%0.0pp | 1.7%+0.2pp | 1.5%+0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Exponent's ratios come from?
- Every ratio is computed from Exponent's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
